Dr. Lewin, Chairman, National Coalition on Health Care applauds @VIMCollab's Action Plan:
"We know VBAs benefit innovators, payers, and most importantly patients, and I hope this roadmap serves to spark the change we need to allow a more favorable environment to support VBAs."
Read the full Action Plan here: vim-collaborative.com/
National Coalition on Health Care retweeted
In our recent briefing with @NC_HC, Dr. Fred Ledley, the director of the Center for Integration of Science and Industry at Bentley University, and a former biotechnology entrepreneur and CEO spoke about the findings.
View the full report here: uploads-ssl.webflow.com/5e59…
National Coalition on Health Care retweeted
Today, 11:15am ET: President Biden lays out elements of his plan to lower Rx drug costs as a key feature of the Build Back Better plan. He calls on Congress to act. @POTUS is listening to the powerful voices of patient advocates. He really understands.
whitehouse.gov/briefing-room…
With 52.7% of #MedicareAdvantage beneficiaries living below 200% of the Federal Poverty Level, policy solutions to address social determinants of health are more important than ever. A new report from @BMAlliance Offers a way forward. bit.ly/3jpfH2n
National Coalition on Health Care retweeted
Thanks for the quote @BLaw from our @WestHealth @NC_HC event last week on #Drug Pricing Reform: The Costs of Inaction. "We want to make sure that any changes that happen will affect people in the commercial market as well as people in the Medicare program" news.bloomberglaw.com/employ…
National Coalition on Health Care retweeted
Honored to join @NC_HC & @WestHealth for Congressional Briefing to discuss evidence that reducing drug prices could inhibit @innovation and new research from @SciIndustry @BentleyU that this may be mitigated by #agile management. Recording now available: nchc.org/events/drug-pricing…
National Coalition on Health Care retweeted
Broad and bipartisan support for government action to lower drug prices. Discussed during recent briefing with @NC_HC and reported via @InHealthPolicy. bit.ly/3C6FBRd
THREAD: Policy does not need to make a false choice between reducing drug prices to ensure #affordability and the #innovation required to develop new cures.
[@SciIndustry, @bentleyu, @WestHealth, @iamamyherr]
Dr. Ledley concludes that strategic allocation of cost reductions by large pharmaceutical companies can mitigate negative impact of revenue reductions from #HR3 on #innovation.
[@scilndustry, @bentleyu, @WestHealth, @iamamyherr]
He emphasizes that industry best practices are robust and can provide patients relief from high #drugprices without slowing #innovation.
[@Scilndustry, @bentleyu, @westhealth, @iamamyherr]
Research from @SciIndustry, @bentleyu finds that small companies have an important role in new #drugdevelopment; data shows small companies conduct about 60% of all clinical trials.
It's not just bipartisan, it's beneficial for all of us," Congressman @PeterWelch emphasized regarding lowering the cost of healthcare and the biggest driver, the escalation of #prescriptiondrug prices.
[@WestHealth, @iamamyherr]
We are grateful to hear remarks from Congressman @PeterWelch during today's briefing.
He spoke to the role of pharmaceutical companies in accessing prescription drugs, the recent #alzheimersdrug, and healthcare affordability at large.
Did you know that 34 million people know someone who has died due to not being able to afford their care?
Participants heard results from a recent study conducted by @WestHealth and @Gallup that included this striking statistic among others. [@iamamyherr]
We are proud to co-host today's briefing on drug pricing reform with @WestHealth. Tune in now!
[@PeterWelch, @SciIndustry, @sgremminger, @iamamyherr, @ElissaSlotkin]
The federal government negotiates the price of many things but not drugs. Join us TOMORROW at 1pm ET to hear from @PeterWelch @ElissaSlotkin @SciIndustry @sgremminger @iamamyherr discuss necessary #drugpricing reform
ow.ly/ru5950FERYI
THIS WEEK! Join us on Wednesday at 1pm ET w/ @WestHealth for a Congressional briefing on the costs of inaction for #DrugPricingReform. Featuring @PeterWelch @ElissaSlotkin @SciIndustry @sgremminger @iamamyherr
Register Here: ow.ly/nTMB50FDGvJ
🚨New speaker announcement!🚨 We are honored to have Congresswoman @ElissaSlotkin join us to provide closing remarks at our briefing on the costs of inaction for #DrugPricingReform w/ @WestHealth on July 28. Register now!
ow.ly/l2xD50FBTw6
Do claims about innovation justify high prescription drug prices? Join us on July 28 w/ @WestHealth to hear from Congressman @PeterWelch @SciIndustry @sgremminger @iamamyherr discuss necessary reform.
Register Here: ow.ly/bVQ550FB6iX












